Acetyldigitoxin
Acetyldigitoxin may decrease the cardiotoxic activities of Anastrozole.
Ancestim
The risk or severity of cytotoxicity can be increased when Ancestim is combined with Anastrozole.
Atorvastatin
The risk or severity of adverse effects can be increased when Anastrozole is combined with Atorvastatin.
Advertisement
Bevacizumab
Bevacizumab may increase the cardiotoxic activities of Anastrozole.
Bevacizumab-Awwb
Bevacizumab may increase the cardiotoxic activities of Anastrozole.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Anastrozole.
Advertisement
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Anastrozole.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Anastrozole.
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Anastrozole.
Advertisement
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Anastrozole.
Cerivastatin
The serum concentration of Cerivastatin can be increased when it is combined with Anastrozole.
Chlorotrianisene
The therapeutic efficacy of Anastrozole can be decreased when used in combination with Chlorotrianisene.
Cyclophosphamide
Cyclophosphamide may increase the cardiotoxic activities of Anastrozole.
Cyclophosphamide Anhydrous
Cyclophosphamide may increase the cardiotoxic activities of Anastrozole.
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Anastrozole.
Dienestrol
The therapeutic efficacy of Anastrozole can be decreased when used in combination with Dienestrol.
Diethylstilbestrol
The therapeutic efficacy of Anastrozole can be decreased when used in combination with Diethylstilbestrol.
Digitoxin
Digitoxin may decrease the cardiotoxic activities of Anastrozole.
Digoxin
Digoxin may decrease the cardiotoxic activities of Anastrozole.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Anastrozole.
Docetaxel
The risk or severity of adverse effects can be increased when Docetaxel is combined with Anastrozole.
DOCETAXEL ANHYDROUS
The risk or severity of adverse effects can be increased when Docetaxel is combined with Anastrozole.
Equol, (-)-
The therapeutic efficacy of Anastrozole can be decreased when used in combination with Equol.
Ergonovine
The risk or severity of adverse effects can be increased when Ergonovine is combined with Anastrozole.
Ergotamine
The risk or severity of adverse effects can be increased when Ergotamine is combined with Anastrozole.
Estradiol
The therapeutic efficacy of Anastrozole can be decreased when used in combination with Estradiol.
Estradiol acetate
The therapeutic efficacy of Anastrozole can be decreased when used in combination with Estradiol acetate.
Estradiol Cypionate
The therapeutic efficacy of Anastrozole can be decreased when used in combination with Estradiol cypionate.
Estradiol Valerate
The therapeutic efficacy of Anastrozole can be decreased when used in combination with Estradiol valerate.
Estriol
The therapeutic efficacy of Anastrozole can be decreased when used in combination with Estriol.
Estrogens, Conjugated (USP)
The therapeutic efficacy of Anastrozole can be decreased when used in combination with Conjugated estrogens.
Estrogens, Esterified (USP)
The therapeutic efficacy of Anastrozole can be decreased when used in combination with Estrogens, esterified.
Estrone
The therapeutic efficacy of Anastrozole can be decreased when used in combination with Estrone.
Ethinyl Estradiol
The therapeutic efficacy of Anastrozole can be decreased when used in combination with Ethinyl Estradiol.
Fluvastatin
The serum concentration of Fluvastatin can be increased when it is combined with Anastrozole.
Genistein
The therapeutic efficacy of Anastrozole can be decreased when used in combination with Genistein.
Ibrutinib
The serum concentration of Ibrutinib can be increased when it is combined with Anastrozole.
Lisuride
The risk or severity of adverse effects can be increased when Lisuride is combined with Anastrozole.
Lovastatin
The serum concentration of Lovastatin can be increased when it is combined with Anastrozole.
Mestranol
The therapeutic efficacy of Anastrozole can be decreased when used in combination with Mestranol.
Metergoline
The risk or severity of adverse effects can be increased when Metergoline is combined with Anastrozole.
Methadone
The serum concentration of Methadone can be increased when it is combined with Anastrozole.
Methylergonovine
The risk or severity of adverse effects can be increased when Methylergometrine is combined with Anastrozole.
Methysergide
The risk or severity of adverse effects can be increased when Methysergide is combined with Anastrozole.
Nicergoline
The risk or severity of adverse effects can be increased when Nicergoline is combined with Anastrozole.
Ouabain
Ouabain may decrease the cardiotoxic activities of Anastrozole.
Ovine Digoxin Immune Fab
Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Anastrozole.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Anastrozole.
Pergolide
The risk or severity of adverse effects can be increased when Pergolide is combined with Anastrozole.
Pitavastatin
The serum concentration of Pitavastatin can be increased when it is combined with Anastrozole.
Polyestradiol Phosphate
The therapeutic efficacy of Anastrozole can be decreased when used in combination with Polyestradiol phosphate.
Pravastatin
The serum concentration of Pravastatin can be increased when it is combined with Anastrozole.
Promestriene
The therapeutic efficacy of Anastrozole can be decreased when used in combination with Promestriene.
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Anastrozole.
Quinestrol
The therapeutic efficacy of Anastrozole can be decreased when used in combination with Quinestrol.
Rilpivirine
The serum concentration of Rilpivirine can be increased when it is combined with Anastrozole.
Rosuvastatin
The serum concentration of Rosuvastatin can be increased when it is combined with Anastrozole.
Simvastatin
The serum concentration of Simvastatin can be increased when it is combined with Anastrozole.
synthetic conjugated estrogens, A
The therapeutic efficacy of Anastrozole can be decreased when used in combination with Synthetic Conjugated Estrogens, A.
synthetic conjugated estrogens, B
The therapeutic efficacy of Anastrozole can be decreased when used in combination with Synthetic Conjugated Estrogens, B.
Tamoxifen
The serum concentration of Anastrozole can be decreased when it is combined with Tamoxifen.
Tibolone
The therapeutic efficacy of Anastrozole can be decreased when used in combination with Tibolone.
Tizanidine
The serum concentration of Tizanidine can be increased when it is combined with Anastrozole.
Tolvaptan
The serum concentration of Tolvaptan can be increased when it is combined with Anastrozole.
Trastuzumab
Trastuzumab may increase the cardiotoxic activities of Anastrozole.